机构:[1]State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission, Chinese Academy of Medical Sciences and Shandong Province, Department of Cardiology, Qilu Hospital of Shandong University, Jinan 250012, China[2]Department of Microbiology, Tumor and Cell Biology, Hong Kong Centre for Cerebro-cardiovascular Health Engineering, Karolinska Institute, 171 65 Stockholm, Sweden[3]Department of Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[4]Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, The Fifth Affiliated Hospital of Wenzhou Medical University, Affiliated Lishui Hospital of Zhejiang University, The Central Hospital of Zhejiang Lishui, Lishui 323000, China[5]Department of Endocrinology, The Affiliated Taian City Central Hospital of Qingdao University, Taian City, Shandong Province, China[6]Clinical Oncology Department, Weifang People’s Hospital, Kuiwen, Weifang, China[7]Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA[8]Eye Institute, Eye and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China[9]Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China[10]Department Nuclear Medicine, Department of Emergency Medicine, Shandong Provincial Clinical Research Center for Emergency and Critical Care Medicine, Institute of Emergency and Critical Care Medicine of Shandong University, Qilu Hospital of Shandong University, Jinan, China
Y. Cao’s laboratory is supported through research grants from the Swedish
Cancer Foundation, the Strategic Research Areas (SFO)–Stem Cell and
Regenerative Medicine Foundation, the Karolinska Institute Foundation, the
NOVO Nordisk Foundation, the Swedish Research Council (project no.
2016-02215, project no. 2019-01502, and project no. 2021-06122), the Swedish Research Council-the National Natural Science Foundation of China joint
grants, the Hong Kong Centre for Cerebro-Cardiovascular Health Engineering,
and the Horizon Europe grant-PERSEUS (action number: 101099423). State
Key Laboratory for Innovation and Transformation of Luobing Theory is supported through research grants from Key R&D Program of Shandong Province
(2021SFGC0503, 2021ZLGX02, 2021ZDSYS05), the National Natural Science
Foundation of China (82241203, 82030051), State Key R&D Program of China
(2021YFF0501403), and the Taishan Scholars Program of Shandong Province
(to C. Zhang).
第一作者机构:[1]State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission, Chinese Academy of Medical Sciences and Shandong Province, Department of Cardiology, Qilu Hospital of Shandong University, Jinan 250012, China[2]Department of Microbiology, Tumor and Cell Biology, Hong Kong Centre for Cerebro-cardiovascular Health Engineering, Karolinska Institute, 171 65 Stockholm, Sweden
通讯作者:
通讯机构:[2]Department of Microbiology, Tumor and Cell Biology, Hong Kong Centre for Cerebro-cardiovascular Health Engineering, Karolinska Institute, 171 65 Stockholm, Sweden[9]Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China